Case Reports
5 October 2015
Vol. 9 No. 4 (2015)
https://doi.org/10.4081/itjm.2015.570

Off-label use of thalidomide for the treatment of a bleeding cutaneous metastasis

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Thalidomide, off-label, bleeding metastasis.
1587
Views
809
Downloads
385
HTML

Authors

Federico Silvestri
silvestrifederico@alice.it
Division of Internal Medicine, General Hospital, Latisana (UD), Italy.
Andrea Da Porto
Division of Internal Medicine, General Hospital, Latisana (UD), Italy.
Antonella Labombarda
Division of Internal Medicine, General Hospital, Latisana (UD), Italy.
Elisa Mansutti
Division of Internal Medicine, General Hospital, Latisana (UD), Italy.
Adolfo Rogato
Division of Internal Medicine, General Hospital, Latisana (UD), Italy.
We herein describe the case of a 65-year-old man with frequent hospitalizations for severe anemia due to several recurrent bleedings of a cutaneous metastasis of hepatocellular carcinoma, and its successful off label treatment with thalidomide therapy for controlling bleeding and reducing transfusion requirements.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite



Off-label use of thalidomide for the treatment of a bleeding cutaneous metastasis. (2015). Italian Journal of Medicine, 9(4), 377-379. https://doi.org/10.4081/itjm.2015.570

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.